Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
$3M Partnership to Accelerate Development of Neuroplastogens for Substance Use Disorder Treatment
Oct 28, 2024•almost 2 years ago
Contract Type
partnership
BoulderBiotechnologyHealth CareTherapeuticsDescription
Tessara Therapeutics, Psylo, and the University of Sydney have secured a $3 million grant to advance brain-rewiring treatments for addiction. The collaboration will focus on the development of neuroplastogens for the treatment of substance use disorders, with an emphasis on methamphetamine addiction, aiming to provide faster, more effective treatments for addiction and other mental health conditions.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months